VTT of Finland Licenses GeneGo's Software for Cancer Studies | GenomeWeb
NEW YORK (GenomeWeb News) – GeneGo said today that the VTT Technical Research Centre of Finland, a developer of novel high-throughput methods for cancer research, drug discovery, and diagnostics, has licensed the company’s software suite.
Under the agreement, VTT will use the MetaCore and MetaDrug software in compound screening, RNA interference experiments, cell biology, and bioinformatics projects to identify pathways and networks for cancer research projects.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.